Good morning, everyone, and nice to see you again, especially after our tech problems late last week. Of course, we now arise to the proverbial 'storm of storms' this morning and have done our best to ensure the Pharmalot corporate campus withstands the onslaught. But one never knows. So, we are brewing the usual cup of stimulation and pursuing our usual routine. Meanwhile, we hope those of you on the East Coast of the US are dry and safe as you peruse some tidbits. Hope your day goes well, wherever you are...
Glaxo And Shionogi Rework ViiV HIV Drug Deal (Reuters)
Canada Pulls Novartis Flu Vaccines (CBC)
Glaxo Chairman To Step Down In Two To Three Years (The Telegraph)
FDA OKs Teva Drug For Chronic Myelogenous Leukemia (Pharma Times)
FDA Panel To Review Heart Risk Of Novo Insulin (Bloomberg News)
J&J Recalls Surgical Stapler Over Safety Risk (Dow Jones)
India's Pharmexcil Fears Generic Name Proposal (Pharmabiz)
Glaxo Starts Final-Stage Tests On Severe Asthma Drug (Reuters)
Six Small CROs Form Development Deal (Kansas City Business Journal)
EDITOR'S NOTE: Please check this post for updates
hurricane pic thx to ani carrington flickr
3 Comments
I hope you're staying safe, Ed!